Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-08-08 16:03:14
Reporting Period:
Filing Date:
Accepted Time:
2017-08-08 16:03:14
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS Pharmaceutical Preparations (2834) CA
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1024000 C James Blair C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-04 18,450 $78.61 17,056 No 4 S Indirect By DP VII Associates, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By DP VII Associates, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000,000 Indirect By Domain Partners VII, L.P.
Common Stock 92,518 Indirect By One Palmer Square Associates VII, LLC
Common Stock 32,760 Indirect By Domain Associates, LLC
Common Stock 2,185 Direct
Common Stock 2,927 Indirect By Susan W. and James C. Blair Family L.P.
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.19 to $79.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P., and of Domain Associates, LLC. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
  3. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.